As shown in Fig. 1c, Cell Counting Kit-8 (CCK8) assay revealed that compared with NC group, a decrease occurred in proliferation ability of glioma cells in the UCA1(−) group (P < 0.05). This evidence concerns the gene UCA1 and central nervous system cancer.